Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

McCormick Scientific

2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
2 INVESTMENTS
Description

Developer and manufacturer of histotechnology tools needed to support cancer screening technologies. The company conducts testing and research works on tissue processing and histopathology tests that are used to diagnose, identify and differentiate various forms of cancer using microscopic tissue samples.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 5918 Evergreen Boulevard
  • Berkeley, MO 63134
  • United States

McCormick Scientific Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore McCormick Scientific‘s full profile, request access.

Request full access to PitchBook

McCormick Scientific Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 01-Dec-2005 0000000000 Other Healthcare Technology Systems 0000000 000000
Tyco International (Paraplast) 07-Jan-2005 Buyout/LBO 00.00 Discovery Tools (Healthcare) 0000000 000000
To view this company’s complete investment and acquisition history, request access »

McCormick Scientific Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore McCormick Scientific‘s full profile, request access.

Request full access to PitchBook

McCormick Scientific Executive Team (4)

Name Title Board
Seat
Contact
Info
Douglas Martin Chief Executive Officer & President
Wayne Kozlen Chief Financial Officer
James McCormick MD Chief Scientific Officer & Partner

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »